ALKS 7106Alternative Names: ALKS7106
Latest Information Update: 28 Feb 2015
At a glance
- Originator Alkermes plc
- Class Opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain